Benitec Biopharma Inc.BNTCNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+39.1%
5Y CAGR+30.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+39.1%/yr
vs +20.2%/yr prior
5Y CAGR
+30.1%/yr
Recent acceleration
Acceleration
+18.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $50.48M | +22.0% |
| 2025 | $41.37M | +85.9% |
| 2024 | $22.25M | +18.5% |
| 2023 | $18.77M | +4.8% |
| 2022 | $17.92M | +32.4% |
| 2021 | $13.53M | +58.0% |
| 2020 | $8.56M | -4.7% |
| 2019 | $8.99M | +3.6% |
| 2018 | $8.68M | +97.0% |
| 2017 | $4.40M | - |